Buy Apollo Hospitals Enter. L, target price Rs 7560: IIFL Securities

On January 01, IIFL Securities issued a buy call on Apollo Hospitals Enterprise Limited (Apollo Hospitals), recommending a target price of Rs. 7560. This recommendation is based on the company's strong fundamentals, including its position as one of the leading healthcare providers in India, with a diversified portfolio of services across hospitals, pharmacies, and diagnostics. Apollo Hospitals has consistently delivered strong financial performance, and the brokerage firm believes that this trend will continue in the future. At the time of the recommendation, the current market price of Apollo Hospitals was Rs. 7397, indicating a potential upside of 2.79%.

About Apollo Hospitals Enter. L:

Apollo Hospitals Enterprise Limited (NSE: APOLLOHOSP) is a leading healthcare provider in Asia with a presence in 15 countries. Founded in 1983, the company operates over 75 hospitals, 4,600 pharmacies, and 100 primary care and diagnostic clinics. Apollo Hospitals offers a wide range of medical services, including cardiology, cancer care, critical care, and joint replacement. The company's commitment to quality healthcare has earned it numerous national and international accreditations.

52 Week Price Trend:

Apollo Hospitals Enterprise Limited (NSE: APOLLOHOSP) is currently trading at Rs. 7397, demonstrating a 2.2% gain from its 52-week low price of Rs 5639.7. However, it has retreated slightly from its 52-week high of Rs. 7545.1. Apollo Hospitals is a leading healthcare provider in India with a strong presence across various segments, including hospitals, pharmacies, and diagnostic services. Its financial performance has been impacted by the COVID-19 pandemic, but it has shown signs of recovery in recent quarters.

Stratzy's MOST Analysis:

Stratzy's MOST framework has assigned APOLLOHOSP an AAA rating, indicating that the company has a strong management team, a positive outlook, high safety, and a favorable trend. This rating suggests that APOLLOHOSP has low fundamental risks and is a relatively safe investment. The company's strong performance in these key areas is likely to continue in the future.

Company's Fundamentals:

Apollo Hospitals (APOLLOHOSP) is a healthcare company listed on the National Stock Exchange (NSE) of India. As of a particular date, its stock was trading at a PE (Price-to-Earnings) ratio of 88.25, implying that investors are willing to pay 88.25 times the company's per-share earnings. The PB (Price-to-Book) ratio of 13.92 indicates that the stock is currently valued at 13.92 times its net asset value, suggesting that investors believe the company is undervalued. The Dividend Yield of 0.22% represents the annual dividend paid per share as a percentage of the current share price, indicating a low level of dividend income relative to the share price.

Fundamental and Technical information provided in this blog were last updated on 01 Jan, 2025

Disclaimer: The information and recommendations presented in this section, including any attached reports, are sourced from third-party providers through diverse channels. The views and opinions expressed within these materials belong solely to their respective creators. These views and opinions do not necessarily reflect the position of Stratzy Fintech Pvt Ltd. Stratzy explicitly disclaims any guarantees, express or implied, regarding the accuracy and reliability of the provided content. We strongly advise consulting with a licensed financial advisor before making any investment decisions based on this information. Remember, seeking independent financial advice is crucial.